[go: up one dir, main page]

CN1171565C - Delivery system for branched implant films - Google Patents

Delivery system for branched implant films Download PDF

Info

Publication number
CN1171565C
CN1171565C CNB998091723A CN99809172A CN1171565C CN 1171565 C CN1171565 C CN 1171565C CN B998091723 A CNB998091723 A CN B998091723A CN 99809172 A CN99809172 A CN 99809172A CN 1171565 C CN1171565 C CN 1171565C
Authority
CN
China
Prior art keywords
distal end
tubular conduit
end portion
described apparatus
body passage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998091723A
Other languages
Chinese (zh)
Other versions
CN1311646A (en
Inventor
唐纳德・R・雷克瑟
唐纳德·R·雷克瑟
A・舒科欧维
乔治·A·舒科欧维
M・宾尼
艾安·M·宾尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
In Accordance With Vichy Austrian Medical Equipment Co ltd
Novo RPS ULC
Nowe GmbH
Original Assignee
Novo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Corp filed Critical Novo Corp
Publication of CN1311646A publication Critical patent/CN1311646A/en
Application granted granted Critical
Publication of CN1171565C publication Critical patent/CN1171565C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/954Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0034Multi-lumen catheters with stationary elements characterized by elements which are assembled, connected or fused, e.g. splittable tubes, outer sheaths creating lumina or separate cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0037Multi-lumen catheters with stationary elements characterized by lumina being arranged side-by-side

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

An endovascular liner comprising a 1 st tubular passageway and a 2 nd tubular passageway, the 1 st tubular passageway comprising a 1 st distal end and a 1 st proximal end, the 2 nd tubular passageway comprising a 2 nd distal end and a 2 nd proximal end, wherein the 2 nd distal end of the 2 nd tubular passageway is secured to the 1 st tubular passageway adjacent the 1 st distal end to define: i) a junction immediately adjacent to a bifurcation in a branching body passageway, ii) an extension in the 1 st tubular passageway distal to the junction for insertion into one of the 1 st and 2 nd body passageways. It can be used to guide a pair of guide wires to a branched body duct so that, once in place, the guide wires are substantially untwisted, i.e. not tangled. This greatly facilitates delivery of the branched stent membrane to the branched artery.

Description

分支植入膜的传送系统Delivery system for branched implant membranes

本发明所属技术领域The technical field of the present invention

本发明相关于为传送分支植入膜所使用的一种血管内衬套。另一方面,本发明相关于分支植入膜的传送用具。再一方面,本发明相关于分支植入膜的传送方法。The present invention relates to an endovascular liner for delivering branch implants. In another aspect, the invention relates to a delivery kit for branch implants. In yet another aspect, the invention relates to methods of delivery of branched implants.

与本发明相关的背景技术Background technology related to the present invention

植入膜是广为人知的。实际上,术语“植入膜”可与有些术语,如“脉管内移植物”和“可扩张的修补物”互换使用。本说明书通篇使用“植入膜”这一专门术语是为了具有广泛的涵意并涵盖用于在到身体通道(如管腔或动脉)内移植的任一可扩张的修补器件。Implanted membranes are well known. In fact, the term "implant" is used interchangeably with terms such as "endovascular graft" and "expandable prosthesis". The term "implantation membrane" is used throughout this specification to have a broad meaning and encompass any expandable prosthetic device intended for implantation within a passageway to the body, such as a lumen or artery.

由于这些器件使用的潜在可能性,在某些场合这些器件的使用可替代外科手术,因而,在过去的10年中,植入膜的使用吸引了越来越多的注意力。通常,在维持身体通道的完整性的同时,一个植入膜被用来获得和维持人体通道的畅通。如本说明书中使用中,术语“身体通道”意图具有广泛的涵意,涵盖人体内的任何管道(天然的和医原性的),并可包括血管、呼吸管道、肠胃管道和类似的任一种管道。The use of implanted membranes has attracted increasing attention over the past decade due to the potential for the use of these devices as an alternative to surgery in some settings. Typically, an implanted membrane is used to obtain and maintain the patency of the body passage while maintaining the integrity of the body passage. As used in this specification, the term "body passage" is intended to have a broad meaning covering any conduit (natural and iatrogenic) in the human body, and may include blood vessels, respiratory tracts, gastrointestinal tracts, and any kind of pipeline.

植入膜的开发已到达了这种程度,即当前可获得的绝大多数植入膜依赖于在身体通道目标上它的整体结构的可控塑性变形,以使得在植入膜扩张期间仅仅施加足够能维持身体通道的畅通的力。Implants have been developed to such an extent that the vast majority of currently available implants rely on controlled plastic deformation of their overall structure on the body passageway target such that only the Sufficient force to maintain the unimpeded passage of the body.

通常,在许多的这类系统中,植入膜结合的气球由导管系统送到身体通道的目标区域。一旦该植入膜被恰当地定位(例如,为在脉管内移植脉管的目标后可以填充以造影剂以便在透视屏上看到),将气球扩充而塑性地变形该植入膜的整体结构,从而将后者紧贴在身体通道上。如上指出的,在维持身体通道畅通的同时,施加力的总量至少须扩张植入膜(即施加的力超过植入膜材料所能承受的塑性变形的最小力)。此时,气球放气并从导管后撤,然后取出。理想地,该植入膜将留在原地,实质上排除身体通道目标区域的堵塞(或狭窄)。Typically, in many of these systems, an implanted membrane-bound balloon is delivered by a catheter system to the target area of the bodily passage. Once the implant is properly positioned (e.g., can be filled with contrast agent to be seen on a see-through screen for the purpose of endovascularly grafting a vessel), the balloon is inflated to plastically deform the overall structure of the implant , thereby fitting the latter against the body channel. As noted above, the amount of force applied must at least expand the implant membrane (ie apply a force that exceeds the minimum force that the implant membrane material can withstand plastic deformation) while maintaining the body passageway open. At this point, the balloon is deflated and withdrawn from the catheter, then removed. Ideally, the implanted membrane will stay in place, substantially precluding blockage (or stenosis) of the targeted area of the bodily passage.

例如,请看下列的专利:For example, see the following patents:

美国专利4,733,665(Palmaz),US Patent 4,733,665 (Palmaz),

美国专利4,739,762(Palmaz),US Patent 4,739,762 (Palmaz),

美国专利4,800,882(Gianturco),US Patent 4,800,882 (Gianturco),

美国专利4,907,336(Gianturco),US Patent 4,907,336 (Gianturco),

美国专利5,035,706(Gianturco et al.),US Patent 5,035,706 (Gianturco et al.),

美国专利5,037,392(Hillstead),US Patent 5,037,392 (Hillstead),

美国专利5,041,126(Gianturco),US Patent 5,041,126 (Gianturco),

美国专利5,102,417(Palmaz),US Patent 5,102,417 (Palmaz),

美国专利5,147,385(Beck et al.),US Patent 5,147,385 (Beck et al.),

美国专利5,282,824(Gianturco),US Patent 5,282,824 (Gianturco),

美国专利5,316,023(Palmaz et al.),US Patent 5,316,023 (Palmaz et al.),

加拿大专利1,239,755(Wallsten),Canadian Patent 1,239,755 (Wallsten),

加拿大专利1,245,527(Gianturco et al.),Canadian Patent 1,245,527 (Gianturco et al.),

加拿大专利申请号2,171,047(Penn et al.),Canadian Patent Application No. 2,171,047 (Penn et al.),

加拿大专利申请号2,175,722(Penn et al.),Canadian Patent Application No. 2,175,722 (Penn et al.),

加拿大专利申请号2,185,740(Penn et al.),Canadian Patent Application No. 2,185,740 (Penn et al.),

加拿大专利申请号2,192,520(Penn et al.),Canadian Patent Application No. 2,192,520 (Penn et al.),

国际专利申请PCT/CA97/00151(Penn et al.),International Patent Application PCT/CA97/00151 (Penn et al.),

国际专利申请PCT/CA97/00152(Penn et al.),和International Patent Application PCT/CA97/00152 (Penn et al.), and

它们每一项的内容特此引证作为讨论有关前述植入膜设计和布放系统的参考。The content of each of them is hereby incorporated by reference for discussions pertaining to the aforementioned implant membrane designs and deployment systems.

在上面提到的专利中,所论及的植入膜都分享通用的单管道设计,因而最适合于直接传送和安放到身体通道中。这类熟知的植入膜不适合于分支身体通道(例如身体通道包括分开成一对通道的母通道)的使用。还有,这类植入膜不适用于带有旁边分支的身体通道,因为:(i)植入膜不准确的放置显著增加了病人的危险,(ii)关闭旁边分支通道的危险增加,以及(iii)旁边分支通道实际将是不可进入的。In the above-mentioned patents, the implanted membranes discussed all share a common single-tube design and are thus best suited for direct delivery and placement in body passages. Such well-known implant membranes are not suitable for use in branching body passages, for example a body passage comprising a parent passage that splits into a pair of passages. Also, such implants are unsuitable for body passages with side branches because: (i) inaccurate placement of the implants significantly increases risk to the patient, (ii) increases risk of closure of side branch passages, and (iii) Side branch passages will not actually be accessible.

确实,在发表的于支持Palmaz-Schatz植入膜的医生导则的32页陈述中(它的内容在此引证作为参考)讲到:Indeed, in a 32-page statement published in the Physician's Guidelines in Support of the Palmaz-Schatz Implantable Membrane (the contents of which are hereby incorporated by reference):

“并无试图使用导引线或气球将PALMAZ-SCHATZ植入膜放到旁边分支中,因为这样的尝试可能导致对目标血管或植入膜的额外的损坏。试图处理在植入段中阻塞的旁边分支可能使气球夹住,使得必须进行紧急外科旁路手术。”“There was no attempt to place the PALMAZ-SCHATZ implant into the side branch using a guide wire or balloon, as such attempts could result in additional damage to the target vessel or the implant. Attempts to address occlusion in the implant segment The side branch could have pinched the balloon necessitating emergency surgical bypass."

例如,在安装时,PALMAZ-SCHATZ植入膜可能会永远完全遮住由身体通道目标区域中发出的旁边分支。这可能发生问题,因为处理阻塞或其它的与旁边分支有关问题的唯一办法是施行要避免安装植入膜类型的外科手术。For example, when installed, the PALMAZ-SCHATZ Implant Membrane may permanently completely obscure side branches emanating from the body channel target area. This can be problematic because the only way to deal with blockages or other problems with side branches is to perform the type of surgery that avoids the installation of implants.

对于常规的单导管植入膜的禁忌是由大量的研究者确证的。例如请看:Contraindications to conventional single-catheter implants have been confirmed by a large number of investigators. See for example:

1.介入心血管医学:原理和实践(1994);出版者:ChurchillLivingstone Inc.;第221-223页(Ohman et al.),667-668页(Bashore et al.)和897页(Bailey et al.),包括在此引用的参考;1. Interventional Cardiovascular Medicine: Principles and Practice (1994); Publisher: Churchill Livingstone Inc.; Pages 221-223 (Ohman et al.), 667-668 (Bashore et al.) and 897 (Bailey et al. .), including references cited herein;

2.Gianturco-Roubin屈曲-植入膜TM冠状植入膜;医生导则;第2页,第3段下的警告;2. Gianturco-Roubin Buckling - ImplantTM Coronary Implant Membrane; Physician's Guide; Page 2, Warning under paragraph 3;

3.循环,83卷,第1期,1991年1月(Schatz et al.);标题“使用Palmaz-Schatz冠状植入膜临床经验”;第148-161页中的第149页;和3. Circulation, Vol. 83, No. 1, January 1991 (Schatz et al.); title "Clinical Experience with Palmaz-Schatz Coronary Implants"; pp. 149 of 148-161; and

4.美国心脏杂志,127卷,第2期,1994年2月(Eeckhout et al.);标题“冠状动脉内植入后的并发症和预后:一个医疗中心6年经验的关键分析”;第262-272页中的第263页,它们每一项的内容均在此引证作为参考。4. American Heart Journal, Vol. 127, No. 2, February 1994 (Eeckhout et al.); Title "Complications and Outcomes After Intracoronary Implantation: A Critical Analysis of One Center's Six-Year Experience"; Page 263 of 262-272, the contents of each of which are hereby incorporated by reference.

再者,有些研究者试图在分支身体通道的每一个分支内安装各别的植入膜。但是,这种方法伴随着至少两个重大的问题。首先,3个各别的植入膜的移植在技术上是个挑战,而且,附带着在移植上需要化极大的力量,结果使身体通道的中心壁承受过度的应力和受创伤,可能导致后面程序的复杂化。其次,因为身体通道分支的中心壁(即在分叉区域)没有受到各别的植入膜支持,身体通道的这一区域基本上保持未受保护而易受被阻塞。Furthermore, some investigators have attempted to install separate implants in each branch of the branching body passages. However, this approach comes with at least two significant problems. First, the grafting of the three separate implants is technically challenging and, with the attendant need for excruciating force on the grafting, results in excessive stress and trauma to the central wall of the bodily passage, which can lead to subsequent program complexity. Second, because the central wall of the branch of the body passage (ie in the bifurcation region) is not supported by the respective implanted membrane, this region of the body passage remains essentially unprotected from being blocked.

分支身体通道的一个特别危险区域出现在冠动脉循环中分支损坏。总的来说,这些损害可分为如下类型:A particularly dangerous area of branching body passages occurs when branch damage occurs in the coronary circulation. In general, these damages can be divided into the following types:

类型         特征Type Features

A            分支前狭窄不涉及侧分支的小孔;A Prebranch stenosis not involving the foramen of the side branches;

B            母管分支后狭窄不涉及侧边分支;B Postbranch stenosis does not involve side branches;

C            围绕侧边分支的狭窄不涉及小孔;C Stenosis around lateral branch not involving foramen;

D            涉及母管和侧分支小孔的狭窄;D Stenosis involving the parent canal and side branch pores;

E            狭窄只涉及侧分支的小孔;和E stenosis involving only the small foramen of the side branches; and

F            狭窄无联地涉及母管和侧分支小孔。F Stenosis involving parent duct and side branch foramen without association.

见介入心脏病学图(Popma et al.),1994,第77-79页,它的内容特此引证作为参考。分支创伤的存在预示着包括急性血管堵塞的处理复杂性的增加。See Interventional Cardiology Atlas (Popma et al.), 1994, pp. 77-79, the contents of which are hereby incorporated by reference. The presence of branch trauma portends increased management complexity including acute vessel occlusion.

美国专利4,994,071(MacGregor),它的内容特此引证作为参考,阐述了分支植入膜的设备。它的专门设计采用一系列由按序的“半-桦条half-birch”相互连接组成的总体上作平行取向的环路。所描述的植入膜的栅格结构是由线材构成的。为了获得所述设计的环路结构,这种线材的使用是重要的。美国专利3,993,078(Bergentz etal.)和5,342,387(Summers),它的内容特此引证作为参考,也阐述和画出了线结构的分支植入膜设计。US Patent 4,994,071 (MacGregor), the contents of which are hereby incorporated by reference, describes a device for implanting branches into a membrane. Its specific design employs a series of generally parallel oriented loops consisting of sequential "half-birch" interconnections. The grid structure of the implanted membrane described is made of wires. The use of such wires is important in order to obtain the designed loop structure. U.S. Patents 3,993,078 (Bergentz et al.) and 5,342,387 (Summers), the contents of which are hereby incorporated by reference, also illustrate and draw branched implant membrane designs of wire structures.

在已公开的加拿大专利申请号2,134,997(Penn et al.)和国际专利申请PCT/CA97/00294(Penn et al.)中,描述了各种新颖的分支植入膜,它们的内容特此引证作为参考。Various novel branched implant membranes are described in Published Canadian Patent Application No. 2,134,997 (Penn et al.) and International Patent Application PCT/CA97/00294 (Penn et al.), the contents of which are hereby incorporated by reference .

美国专利5,749,825(Fischell et al.)描述了植入膜传送导管系统,它的内容特此引证作为参考。US Patent 5,749,825 (Fischell et al.) describes an implantable membrane delivery catheter system, the contents of which are hereby incorporated by reference.

这样,虽然分支植入膜被广为人知,但关于它的基础知识比起单管道植入膜明显地欠缺。并不奇怪,关于这类植入膜的传送系统有类似的知识上的不平衡。特别是,适用于单管植入膜传送系统的知识相比于已有的分支植入膜传送系统的知识要丰富得多。Thus, while branched implants are widely known, basic knowledge about them is significantly less than that of single-channel implants. Not surprisingly, there is a similar imbalance in knowledge regarding delivery systems for such implanted membranes. In particular, much more knowledge is available for single-tube implanted membrane delivery systems than for branched implanted membrane delivery systems.

在任何植入膜(单管道或分支)传送中,都有理由接受这样的方式,植入膜被安装在导管上,该导管由一通过导引导管早先穿入的导引线被引导到目标位置。这样,当目的是要传送一个分支植入膜时,它将面对着将要使用一对的导引线--即每一条线用于由初级身体通道上分支出的两条通道中的一个。因而,重要的是,在初级通道中,无论是在导引导管里还是在通道里导引线均不能相互缠绕,因为这将阻止导管被引导到目标位置。另外,导引导管的被限制的尺寸决定了分支植入膜传送系统的庞大。它的实际结果是现在的传送分支植入膜方法笨拙、,麻烦和技术复杂。至今,本的发明人还没有看到对常规的分支植入膜传送问题的答案。In any implant (single-tunnel or branched) delivery, it is reasonable to accept that the implant is mounted on a catheter that is guided to the target by a guide wire previously threaded through the guide catheter. Location. Thus, when the purpose is to deliver a branching implant, it will face the guide wires for which a pair will be used - ie one for each of the two channels branching off from the primary body channel. It is therefore important that in the primary channel neither the guide wires nor the guide wires become entangled with each other in the channel as this would prevent the catheter from being guided to the target site. Additionally, the limited size of the guide catheter dictates the bulkiness of the branch implant delivery system. The net result of this is that the current method of delivering branch implants to membranes is cumbersome, cumbersome and technically complex. To date, the inventors of the present invention have not seen an answer to the conventional problem of branch implant membrane delivery.

据此,希望有一种能够以基本上不缠结的状态引导一对导引线的系统,以方便分支植入膜的传送。也更希望这样的系统相对与常规的分支植入膜传送系统小型化的优点。Accordingly, it would be desirable to have a system capable of guiding a pair of guide wires in a substantially untangled state to facilitate delivery of branch implant membranes. The advantages of the miniaturization of such a system relative to conventional branch implant membrane delivery systems are also highly desirable.

发明简述Brief description of the invention

本发明的一个目标是提供一种新颖的分支植入膜传送系统,它克服或缓解前面提到的先有技术的至少一个缺点。It is an object of the present invention to provide a novel branch implant membrane delivery system which overcomes or alleviates at least one of the aforementioned disadvantages of the prior art.

因而,一方面,本发明提供一种用于传送一对导引线到分支身体通道的血管内衬套,该衬套包括相互固定的第1管状通道和第2管状通道,第1管状通道包括第1远侧端和第1近侧端,第2管状通道包括第2远侧端和第2近侧端,第1远侧端长于第2远侧端从而定义了一个一个接点,该接点紧靠分支身体通道的分叉点。Thus, in one aspect, the present invention provides an intravascular liner for delivering a pair of guide wires to a branched body passage, the liner comprising a first tubular channel and a second tubular channel fixed to each other, the first tubular channel comprising The first distal end and the first proximal end, the second tubular channel includes the second distal end and the second proximal end, the first distal end is longer than the second distal end so as to define a joint, the joint is tightly By the bifurcation point of the branching body channel.

一套传送分支植入膜到分支身体通道的分支植入膜传送用具,用于传送修补植入膜到分支身体通道,该分支身体通道包括第1身体通道、第2身体通道、以及二者之间的分叉部分,该用具包括:A set of branch implant membrane delivery kits for delivering branch implant membranes to branch body passages, for delivering repair implant membranes to branch body passages, the branch body passages including the first body passage, the second body passage, and the two Forks between, the kit includes:

一血管内衬套,包括第1管状通道和第2管状通道,第1管状通道包括第1远侧端和第1近侧端,第2管状通道包括第2远侧端和第2近侧端,该第2管状通道的第2远侧端固定到该第1管状通道,邻近第1远侧端,以确定:i)一紧靠分支身体通道的分叉点的接点,ii)该接点的远侧的该第1管状通道中的延伸部分,用于插入该第1身体通道或第2身体通道之一;An intravascular liner, comprising a first tubular passage including a first distal end and a first proximal end, and a second tubular passage comprising a second distal end and a second proximal end , the second distal end of the second tubular channel is secured to the first tubular channel adjacent to the first distal end to define: i) a junction close to the bifurcation point of the branching body passage, ii) the junction of an extension in the distal first tubular passage for insertion into one of the first or second body passage;

第1导引线,用于插入该衬套的第2管状通道;The first guide wire is used to insert the second tubular channel of the bushing;

第2导引线,用于插入该衬套的第2管状通道;以及a second guide wire for insertion into the second tubular channel of the liner; and

一导管,用于在传送第1导引线和第2导引线至该分支通道后传递该第1导引线和第2导引线。A catheter for passing the first guide wire and the second guide wire after delivering the first guide wire and the second guide wire to the branch channel.

另一方面,本发明提供了传送一个分支植入膜到目标分支身体通道的传送方法,该目标分支身体通道有一个近侧身体通道,第1远的身体通道和第2远侧身体通道,传送使用一个血管内衬套,该衬套包括相固定的第1管状通道和第2管状通道,第1管状通道包括第1远侧端和第1近侧端,第2管状通道包括第2远侧端和第2近侧端,第1远侧端长于第2远侧端从而定义了一个接点,该接点紧靠分支身体通道的分叉点。该方法包括如下步骤:In another aspect, the present invention provides a delivery method for delivering a branch implant to a target branch body passage having a proximal body passage, a first distal body passage and a second distal body passage, delivering An intravascular liner is used, the liner includes a fixed first tubular channel and a second tubular channel, the first tubular channel includes a first distal end and a first proximal end, and the second tubular channel includes a second distal end end and a second proximal end, the first distal end being longer than the second distal end so as to define a junction that abuts the bifurcation point of the branching body passage. The method comprises the steps of:

(i)引导第1导引线穿过初级近侧身体通道进入到第1远侧身体通道;(i) directing the first guidewire through the primary proximal body passage and into the first distal body passage;

(ii)将血管内衬套的第1管状通道套在这第1导引线上;(ii) Put the first tubular channel of the intravascular liner on the first guide wire;

(iii)引导血管内衬套穿过初始的最近的身体通道直至第1远侧端被置于到第1远侧身体通道并使接点邻近分支身体通道分叉点;(iii) guiding the endovascular liner through the initial proximal body passage until the first distal end is placed into the first distal body passage with the junction adjacent to the branching body passage bifurcation point;

(iv)引导第2导引线穿过第2管状通道并进入到第2远侧身体通道;(iv) guiding a second guidewire through the second tubular channel and into the second distal body channel;

(v)从身体通道中撤出血管内衬套;(v) withdrawing the endovascular liner from the body passage;

(vi)在第1导引线第2导引线上导入一其上配置有分支植入膜的导管;(vi) introducing a catheter with a branched implanted membrane on the first guide wire and the second guide wire;

(vii)引导该分支植入膜到分支身体通道目标区域;和(vii) directing the branch implant membrane to a branch body channel target area; and

(viii)扩张该分支植入膜。(viii) expanding the branch implant membrane.

这样,本发明开发了一个能被用来引导一对导引线到分支身体通道的血管内衬套,使得,一旦到位,导引线实际上不扭拧即不会缠结。这极大地便利了传送分支植入膜到分支的动脉。Thus, the present invention develops an endovascular liner that can be used to guide a pair of guide wires into branching body passages such that, once in place, the guide wires are virtually untwisted and tangle-free. This greatly facilitates delivery of branch implants to branch arteries.

附图简要描述Brief description of the drawings

本发明的优选实例的叙述将参考这里的附图,图中相同编号为标明同样部件:The description of the preferred embodiments of the present invention will refer to the drawings herein, in which like numbers designate like parts:

图1示出了本发明的血管内衬套的第1个优选实例的侧视图;Fig. 1 shows the side view of the first preferred example of the intravascular liner of the present invention;

图2示出了本发明的血管内衬套的第2个优选实例的侧视图;Fig. 2 shows the side view of the second preferred example of the intravascular liner of the present invention;

图3-7示出了如何使用本发明的血管内衬套传送一对导引线的放大图;Figures 3-7 show enlarged views of how a pair of guidewires are delivered using the intravascular liner of the present invention;

图8-12示出了如何使用本发明的血管内衬套传送一对导引线的透视图;8-12 show perspective views of how to deliver a pair of guidewires using the intravascular liner of the present invention;

图13-15示出了如何在一对导引线引导到位时传送分支的植入膜的放大图;和Figures 13-15 show enlarged views of how the implanted membranes deliver the branches when a pair of guidewires are guided into place; and

图16示出了在图13-15中传送的分支植入膜植入的放大图。Figure 16 shows an enlarged view of the implantation of the branch implant membrane delivered in Figures 13-15.

优选实施例的详细描述Detailed description of the preferred embodiment

参看图1,那里示出了一个血管内衬套10。血管内衬套10包括具有第1远侧端22和第1近侧端24的第1管状通道20。血管内衬套10还包括具有第2远侧端32和第2近侧端34的第2管状通道30。第1管状通道20和第2管状通道30彼此沿衔接缝40相结合和固定。如示出的,第1远侧端22伸出超过第2远侧端32。该两个远侧端间的这个差定义了一个接点45。最好第1远侧端22伸出超过第2远侧端32至少约0.3cm的范围,更希望有约0.3~约3cm极限范围。最希望有约0.5~约2cm极限范围。还有,第1近侧端24显著地偏离第2近侧端34。如将在下面展示的,这一偏离使得血管内衬套10象“通过线材/单轨”的传送系统。正如所示的,第1远侧端22和第2远侧端32都是被倒角即作成斜角。Referring to Figure 1, an intravascular liner 10 is shown. The endovascular liner 10 includes a first tubular channel 20 having a first distal end 22 and a first proximal end 24 . The endovascular liner 10 also includes a second tubular channel 30 having a second distal end 32 and a second proximal end 34 . The first tubular channel 20 and the second tubular channel 30 are combined and fixed along the connecting seam 40 . As shown, the first distal end 22 protrudes beyond the second distal end 32 . This difference between the two distal ends defines a junction 45 . Preferably, the first distal end 22 protrudes beyond the second distal end 32 by at least about 0.3 cm, more desirably by a limit of about 0.3 to about 3 cm. Most desirably there is a limit range of about 0.5 to about 2 cm. Also, the first proximal end 24 is significantly offset from the second proximal end 34 . As will be demonstrated below, this offset allows the endovascular liner 10 to resemble an "over the wire/monorail" delivery system. As shown, both the first distal end 22 and the second distal end 32 are chamfered or beveled.

参看图2,那里示出了一个血管内衬套100。血管内衬套100包括具有第1远侧端122和第1近侧端124的第1管状通道120。血管内衬套100还包括具有第2远侧端132和第2近侧端134的第2管状通道130。第1管状通道120和第2管状通道130是彼此沿衔接缝140相连接和固定。如示出的,,第1远侧端122超过第2远侧端132。第1远侧端122和第2远侧端132之间的这个偏差定义一接点145。最好第1远侧端122伸出超过第2远侧端132至少约0.3cm的范围,更希望有约0.3~约3cm极限范围,最希望有约0.5~约2cm极限范围。另外,不象在图1中示出的“通过线材/单轨”的传送系统,第1近侧端124实际上与第2近侧端134基本对齐。这种第1近侧端124与第2近侧端134相互对象的布置使得血管内衬套100象一个“双重通过线材”的传送系统。正如所示的,第1远侧端122和第2远侧端132都是被倒角即作成斜角。Referring to Figure 2, an intravascular liner 100 is shown. The endovascular liner 100 includes a first tubular channel 120 having a first distal end 122 and a first proximal end 124 . The endovascular liner 100 also includes a second tubular channel 130 having a second distal end 132 and a second proximal end 134 . The first tubular channel 120 and the second tubular channel 130 are connected and fixed to each other along the connecting seam 140 . As shown, the first distal end 122 extends past the second distal end 132 . This offset between the first distal end 122 and the second distal end 132 defines a junction 145 . Preferably, the first distal end 122 protrudes beyond the second distal end 132 by at least about 0.3 cm, more desirably from about 0.3 to about 3 cm, and most desirably from about 0.5 to about 2 cm. Additionally, unlike the "over the wire/monorail" delivery system shown in FIG. 1 , the first proximal end 124 is actually substantially aligned with the second proximal end 134 . This reciprocal placement of the first proximal end 124 and the second proximal end 134 makes the endovascular liner 100 resemble a "dual pass wire" delivery system. As shown, both the first distal end 122 and the second distal end 132 are chamfered or beveled.

用于构建血管内衬套10的材料没有具体的限制,当然它:(i)基本上为完整以便能被引导通过曲折的身体通道,和(ii)对于血管内衬套10将被引导通过的对象无毒。适当材料的没有限制的例子包括促生长的聚脂,柔韧的金属管等。The material used to construct the endovascular liner 10 is not particularly limited, although it is: (i) substantially intact so as to be able to be guided through tortuous body passages, and (ii) suitable for the material through which the endovascular liner 10 will be guided. Subject is non-toxic. Non-limiting examples of suitable materials include growth promoting polyester, flexible metal tubing, and the like.

参看图3-7,将讨论使用血管内衬套10来传送一对导引线。Referring to Figures 3-7, the use of the intravascular liner 10 to deliver a pair of guidewires will be discussed.

正如所示的,分支的身体通道50包括一最近程通道52和一对远程通道54,56。远程通道54,56接点定义了一个分叉点58。为了清楚起见,没有示出分支身体通道50内的狭窄。As shown, the branched body channel 50 includes a proximal channel 52 and a pair of remote channels 54,56. The junction of the remote channels 54, 56 defines a branching point 58. Stenosis within branch body passage 50 is not shown for clarity.

参看图3,第1导引线60在箭头A方向上通过最近程通道52被引导到远程通道54中。Referring to FIG. 3 , the first guide wire 60 is guided in the direction of arrow A through the proximal channel 52 into the remote channel 54 .

参看图4,第1管状通道20在箭头方向A上被套到导引线60上直至它进入到远程通道54,血管内衬套10的接点40紧靠分支身体通道50的分叉点58。在示出的实例中,血管内衬套10还被设置有在接点40或其附近的不透射线的标记(例如由金或类似的材料制成)因而,接点40和分叉点58的相对位置可以使用常规的影象射线照相技术来监控。一旦血管内衬套10以这种方式安放,第2管状通道30的第2远侧端32即通往远侧端通道56。Referring to FIG. 4 , the first tubular channel 20 is pulled over the guide wire 60 in the direction of arrow A until it enters the remote channel 54 , and the junction 40 of the endovascular liner 10 abuts the bifurcation point 58 of the branching body channel 50 . In the example shown, the endovascular liner 10 is also provided with a radiopaque marker (eg, made of gold or similar material) at or near the junction 40 . The location can be monitored using conventional video radiography techniques. Once the endovascular liner 10 is positioned in this manner, the second distal end 32 of the second tubular channel 30 opens into the distal end channel 56 .

参看图5,一旦血管内衬套10到位(即,如图4所示),第2导引线62也在箭头A的方向上穿过第2管状通道30进入远程通道56。Referring to FIG. 5 , once the endovascular liner 10 is in place (ie, as shown in FIG. 4 ), the second guide wire 62 is also passed in the direction of arrow A through the second tubular channel 30 into the distal channel 56 .

参看图6,一旦导引线60,62被正确地放置,即将血管内衬套10在箭头B的方向从分支身体通道50后撤。对熟悉本技术的人员将很显见,必须仔细操作以避免血管内衬套10的扭拧,因为这将导致此扭拧传递到导引线60,62。Referring to FIG. 6 , once the guide wires 60 , 62 are properly positioned, the endovascular liner 10 is withdrawn from the branch body channel 50 in the direction of arrow B. Referring now to FIG. It will be apparent to those skilled in the art that care must be taken to avoid twisting of the endovascular liner 10 as this would cause this twisting to be transmitted to the guide wires 60,62.

参看图7,一旦血管内衬套10完全从分支的身体通道50撤出,导引线60和62分别将其远侧端留在远程通道54,56中。Referring to Fig. 7, once the endovascular liner 10 is fully withdrawn from the branched body passage 50, the guide wires 60 and 62 leave their distal ends in the distal passages 54, 56, respectively.

参看图8-12,那里分别列出了如上面讨论的图3-7中使用血管内衬套10传送一对导引线的透视图。Referring to Figures 8-12, there are shown perspective views of a pair of guidewires delivered using the intravascular liner 10 as discussed above in Figures 3-7, respectively.

如示出的,血管内衬套10通过在对象70的腹股沟附近的一个适当的切口被引导到对象70。总的来说,在图8-12中的透视图与图3-7中所示的放大图的对应关系为:As shown, endovascular liner 10 is guided to subject 70 through a suitable incision near the groin of subject 70 . In general, the correspondence between the perspective view in Figure 8-12 and the enlarged view shown in Figure 3-7 is:

图8对应于图3;Figure 8 corresponds to Figure 3;

图9和图10对应于图4;Figure 9 and Figure 10 correspond to Figure 4;

图11对应于图5;和Figure 11 corresponds to Figure 5; and

图12对应于图6和7。FIG. 12 corresponds to FIGS. 6 and 7 .

如上讨论的,血管内衬套10可以被看作“通过线材/单轨”的传送系统。这就意味着,一旦衬套处于正确的位置,一个管状通道(30)仍套在导引线(62)上,以使得其近侧端(34)由由对象发出,而另一管状通道(20)的近侧端(24)则不由对象发出。换言之,在分支身体通道(50)与对象(70)的切口(72)之间的另一管状通道(20)的部分没有完全地套住另一导引线(60)。As discussed above, the endovascular liner 10 can be viewed as a "over the wire/monorail" delivery system. This means that once the bushing is in the correct position, one tubular channel (30) remains over the guide wire (62) so that its proximal end (34) emerges from the subject, while the other tubular channel ( The proximal end (24) of 20) does not emanate from the subject. In other words, the portion of the other tubular channel (20) between the branching body channel (50) and the incision (72) of the subject (70) does not completely entrap the other guide wire (60).

如上讨论的,血管内衬套100可以被看作“双重通过线材”的传送系统。这就意味着,一旦衬套处在正确位置,两个管状通道(120,130)均分别留在它们的导引线(60,62)上,以使得,每个管状通道(120,130)的近侧端(24)由对象发出。换言之,一导引线(60,62)实际上都被血管内衬套100全部覆盖。As discussed above, the endovascular liner 100 can be viewed as a "dual pass-through wire" delivery system. This means that once the bushing is in the correct position, both tubular channels (120, 130) are left on their respective guide wires (60, 62) such that each tubular channel (120, 130) The proximal end (24) of the tube is emitted by the subject. In other words, a guide wire ( 60 , 62 ) is virtually entirely covered by the endovascular liner 100 .

参看图7,当移走血管内衬套时,导引线60和62如图示的留在它们由对象放射的点上,并且实际上没有扭拧。参看图13,在这一点上,导管80被用来传送分支的植入膜到分支身体通道50。具体地,导管80包括有一对从其一端的管子84,86的气球82。分支的植入膜88被安装在气球82上。管子84和86是常规的环型设计,这样它们可以分别被布放在其导引线上,并可以接受充填到气球82中使它扩张的流体。因此,导管80在导引线60和62上被引导直至分支植入膜到达正确的位置-见图14。在这一点上,加压的流体(如盐水)通过管子84,86被引进到气球82,导致气球82和植入膜88扩张-见图15。之后,气球82常规地减压并从分支身体通道50后撤留下植入膜88于放置的位置-见图16。尽管气球82如所示为相邻的单个气球对,但熟悉本技术的人士将会理解,分支的气球也可能被用来替代一对单个气球。Referring to Fig. 7, when the intravascular liner is removed, the guide wires 60 and 62 remain as shown at the point where they emanate from the subject, and are virtually untwisted. Referring to FIG. 13 , at this point, a catheter 80 is used to deliver the branched implant membrane to the branched body channel 50 . Specifically, catheter 80 includes a balloon 82 with a pair of tubes 84, 86 extending from one end thereof. A branched implant membrane 88 is mounted on the balloon 82 . Tubes 84 and 86 are of conventional annular design so that they can each be routed over their guide wires and receive the fluid that fills balloon 82 to expand it. Thus, the catheter 80 is guided over the guide wires 60 and 62 until the branch implant reaches the correct position - see FIG. 14 . At this point, pressurized fluid (such as saline) is introduced into the balloon 82 through the tubes 84, 86, causing the balloon 82 and implant membrane 88 to expand—see FIG. 15 . The balloon 82 is then routinely depressurized and withdrawn from the branch body channel 50 leaving the implant membrane 88 in place - see FIG. 16 . Although balloons 82 are shown as adjacent pairs of individual balloons, those skilled in the art will understand that branched balloons could also be used in place of a pair of individual balloons.

虽然是参照实例阐述本发明,但这些阐述并不意味着具有限制意义。显然,对于业界人员来说,依照这样说明所述实例的各种修改以及其它的发明实例都将是十分显见的。While the invention has been described with reference to examples, these descriptions are not meant to be limiting. Obviously, various modifications of the described examples, as well as other inventive examples, from such descriptions will be apparent to those skilled in the art.

Claims (31)

1. be used to transmit a kind of endovascular sleeve of a pair of guide wire to branch's body passage, this branch's body passage comprises the 1st body passage, the 2nd body passage, and the forked section between the two, this lining comprises the 1st tubular conduit and the 2nd tubular conduit, the 1st tubular conduit comprises the 1st distal end portion and the 1st proximal end, the 2nd tubular conduit comprises the 2nd distal end portion and the 2nd proximal end, it is characterized in that, the 2nd distal end portion of the 2nd tubular conduit is fixed to the 1st tubular conduit and contiguous the 1st distal end portion, to determine: an i) contact near the bifurcation in branch's body passage, the ii) extension in the 1st tubular conduit, in the distally of this contact, be used to insert one of the 1st body passage and the 2nd body passage.
2. by the described endovascular sleeve of claim 1, comprise that also one puts the radio opaque markers of setting in this lining blood vessels.
3. by the described endovascular sleeve of claim 2, this radio opaque markers is placed the contact place by society.
4. by the described endovascular sleeve of claim 1, wherein the 1st tubular conduit has round cross section.
5. by the described endovascular sleeve of claim 1, wherein the 2nd passage has round cross section.
6. by the described endovascular sleeve of claim 1, wherein the 1st passage and the 2nd passage all have round cross section.
7. by any described endovascular sleeve among the claim 1-6, wherein the length of this extension is 0.3cm at least.
8. by any described endovascular sleeve among the claim 1-6, wherein the length of this extension is 0.3~3cm.
9. by any described endovascular sleeve among the claim 1-6, wherein the length of this extension is 0.5~2cm.
10. by any described endovascular sleeve among the claim 1-6, wherein the 1st distal end portion is chamfering.
11. by any described endovascular sleeve among the claim 1-6, wherein the 2nd distal end portion is chamfering.
12. by any described endovascular sleeve among the claim 1-6, wherein the 1st distal end portion and the 2nd distal end portion all are chamferings.
13. a cover bifurcated stent transmits apparatus, is used for transmitting repairing implanting film to branch's body passage, this branch's body passage comprises the 1st body passage, the 2nd body passage and the forked section between the two, and described apparatus comprises:
One endovascular sleeve, comprise the 1st tubular conduit and the 2nd tubular conduit, the 1st tubular conduit comprises the 1st distal end portion and the 1st proximal end, the 2nd tubular conduit comprises the 2nd distal end portion and the 2nd proximal end, the 2nd distal end portion that it is characterized in that the 2nd tubular conduit is fixed to the 1st tubular conduit and contiguous the 1st distal end portion, to determine: an i) contact near the bifurcation of branch's body passage
Ii) the extension in the 1st tubular conduit in the distally of this contact, is used to insert one of the 1st body passage and the 2nd body passage;
The 1st guide wire is used to insert the 2nd tubular conduit of this lining;
The 2nd guide wire is used to insert the 2nd tubular conduit of this lining; And a conduit, be used for to this branched bottom, transmitting the 1st guide wire and the 2nd guide wire transmitting the 1st guide wire and the 2nd guide wire.
14. by the described apparatus of claim 13, this endovascular sleeve comprises that also one is arranged at the radio opaque markers that this lining blood vessels puts.
15. by the described apparatus of claim 14, wherein this radio opaque markers is set on the contact.
16. by the described apparatus of claim 13, wherein the 1st tubular conduit has round cross section.
17. by the described apparatus of claim 13, wherein the 2nd tubular conduit has round cross section.
18. by the described apparatus of claim 13, wherein the 1st tubular conduit and the 2nd tubular conduit all have round cross section.
19. by any described apparatus among the claim 13-18, wherein this extension length is at least 0.3cm.
20. by any described apparatus among the claim 13-18, wherein this extension length is 0.3~3cm.
21. by any described apparatus among the claim 13-18, wherein this extension length is 0.5~2cm.
22. by any described apparatus among the claim 13-18, wherein the 1st distal end portion is chamfering.
23. by any described apparatus among the claim 13-18, wherein the 2nd distal end portion is chamfering.
24. by any described apparatus among the claim 13-18, wherein the 1st distal end portion and the 2nd distal end portion all are chamferings.
25. by any described apparatus among the claim 13-18, wherein conduit comprises distensible parts at least.
26. by the described apparatus of claim 25, wherein distensible component configuration is near the distal end portion of conduit.
27. by the described apparatus of claim 25, wherein conduit comprises two distensible parts.
28. by the described apparatus of claim 25, wherein conduit comprises that one is the expandable member of Y-type.
29. by any described apparatus in the claim 25, wherein distensible parts are balloons.
30., comprise that also one is configured in the expansible prosthesis on the expandable member by the described apparatus of claim 25.
31. by the described apparatus of claim 30, wherein this distensible prosthesis is assembled on these distensible parts.
CNB998091723A 1998-07-31 1999-07-29 Delivery system for branched implant films Expired - Fee Related CN1171565C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9495098P 1998-07-31 1998-07-31
US60/094,950 1998-07-31

Publications (2)

Publication Number Publication Date
CN1311646A CN1311646A (en) 2001-09-05
CN1171565C true CN1171565C (en) 2004-10-20

Family

ID=22248112

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998091723A Expired - Fee Related CN1171565C (en) 1998-07-31 1999-07-29 Delivery system for branched implant films

Country Status (7)

Country Link
EP (1) EP1100410A1 (en)
JP (1) JP4435981B2 (en)
CN (1) CN1171565C (en)
AU (1) AU762447B2 (en)
CA (1) CA2339133C (en)
NZ (2) NZ510186A (en)
WO (1) WO2000007523A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7220275B2 (en) 1996-11-04 2007-05-22 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
WO2001043809A1 (en) * 1999-12-16 2001-06-21 Advanced Cardiovascular Systems, Inc. Catheter assembly and method for positioning the same at a bifurcated vessel
US7578841B2 (en) 2001-09-24 2009-08-25 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7090694B1 (en) 2003-11-19 2006-08-15 Advanced Cardiovascular Systems, Inc. Portal design for stent for treating bifurcated vessels
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
US8882826B2 (en) 2006-08-22 2014-11-11 Abbott Cardiovascular Systems Inc. Intravascular stent
US8834554B2 (en) 2006-08-22 2014-09-16 Abbott Cardiovascular Systems Inc. Intravascular stent
US8216267B2 (en) 2006-09-12 2012-07-10 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
CN102014792B (en) * 2008-05-10 2015-11-25 奥巴斯尼茨医学公司 Cannula for placing stent over delivery balloon catheter system
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
WO2018200942A2 (en) 2017-04-27 2018-11-01 Medtronic Inc. Transcatheter stented prosthesis tensioning and locking systems and devices

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134402A (en) * 1976-02-11 1979-01-16 Mahurkar Sakharam D Double lumen hemodialysis catheter
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4907336A (en) 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US5037392A (en) 1989-06-06 1991-08-06 Cordis Corporation Stent-implanting balloon assembly
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5167623A (en) * 1990-12-27 1992-12-01 The Kendall Company Multilumen catheter
CA2134997C (en) * 1994-11-03 2009-06-02 Ian M. Penn Stent
US5669924A (en) * 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
FR2740346A1 (en) * 1995-10-30 1997-04-30 Debiotech Sa ANGIOPLASTY DEVICE FOR ARTERIAL BIFURCATION
FR2749160B1 (en) * 1996-05-28 1999-05-21 Patrice Bergeron MODULAR BIFURCED VASCULAR PROSTHESIS
US5749825A (en) * 1996-09-18 1998-05-12 Isostent, Inc. Means method for treatment of stenosed arterial bifurcations
US5807311A (en) * 1996-11-29 1998-09-15 Palestrant; Aubrey M. Dialysis catheter having rigid and collapsible lumens and related method

Also Published As

Publication number Publication date
NZ527648A (en) 2005-04-29
AU5023199A (en) 2000-02-28
AU762447B2 (en) 2003-06-26
CA2339133C (en) 2008-11-18
JP2002522114A (en) 2002-07-23
WO2000007523A1 (en) 2000-02-17
NZ510186A (en) 2003-10-31
EP1100410A1 (en) 2001-05-23
JP4435981B2 (en) 2010-03-24
CA2339133A1 (en) 2000-02-17
CN1311646A (en) 2001-09-05

Similar Documents

Publication Publication Date Title
CN1171565C (en) Delivery system for branched implant films
JP5526311B2 (en) Thorax guide
CN1165264C (en) Endoluminal prosthesis for branching and method for manufacturing same
US9474640B2 (en) Vessel bifurcation stent deployment system with zippered catheters
US20090254167A1 (en) Bifurcated stent delivery system and method of use
EP2268227B1 (en) Bifurcated graft deployment systems
CN1271980C (en) Intraluminal grafting of bifurcated artery
CA2598931C (en) Multiple in vivo implant delivery device
CN109567991A (en) conveying sheath
US20130066413A1 (en) Surgical apparatus for aneurysms
US20060155366A1 (en) Apparatus and method for deploying an implantable device within the body
EP2749253B1 (en) Endoluminal prosthesis having modular branches
CN112842619B (en) Bow part tectorial membrane support and tectorial membrane support conveyer
JP2010520026A (en) Intravascular placement device
CN109938895A (en) fenestrated stent graft
WO2018072432A1 (en) Luminal stent
CN203677329U (en) Novel bracket releasing device
WO2007016821A1 (en) A surgical stent peosthesis and a transporter for transporting the peostheses
CN214857826U (en) Bow covered stent and covered stent conveyor
CN113384381B (en) Medical device
CN103561808B (en) There is the guide catheter of the radiopaque filament for locating oral area
JP2008539954A (en) Guide wire loading device for bifurcated blood vessels
CN111407463B (en) Covered stent system
Liu et al. Newly designed “pieced” stent in a rabbit model of benign esophageal stricture
CN219803847U (en) Conveying device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: EVERSIO MEDICAL EQUIPMENT CO., LTD.

Free format text: FORMER NAME OR ADDRESS: NOVI CO., LTD.

Owner name: EVICHIO MEDICAL EQUIPMENT UNLIMITED LIABILITY COMP

Free format text: FORMER NAME OR ADDRESS: EVERSIO MEDICAL EQUIPMENT CO., LTD.

Owner name: NOVI CO., LTD.

Free format text: FORMER NAME OR ADDRESS: NOVO RPS ULC

CP03 Change of name, title or address

Address after: Nova Scotia Canada

Patentee after: NOVO RPS ULC

Address before: Nova Scotia Canada

Patentee before: In accordance with the Vichy Austrian medical equipment Co.,Ltd.

Address after: Nova Scotia Canada

Patentee after: In accordance with the Vichy Austrian medical equipment Co.,Ltd.

Address before: British Columbia

Patentee before: Nowe GmbH

Address after: British Columbia

Patentee after: NOWE GmbH

Address before: British Columbia

Patentee before: Novo Corp.

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1067251

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041020

Termination date: 20140729

EXPY Termination of patent right or utility model